Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
Efbemalenograstim alpha (Ryzneuta) (7 trials)
Filgrastim (neupogen) (2 trials)
cyclophosphamide (cytoxan) (3 trials)
docetaxel (taxotere) (1 trial)
doxorubicin (Doxil) (1 trial)
epirubicin (ellence) (2 trials)
interleukin-22 igg2-fc (1 trial)
prednisone (meticorten) (1 trial)
sargramostim (leukine) (1 trial)
A-319 (1 trial)
Breast Neoplasms (Phase 3)
Graft vs Host Disease (Phase 2)
Lymphoma (Phase 1)
Lymphoma, B-Cell (Phase 1)
Neutropenia (Phase 3)
Trials (9 total)
Trial APIs (10 total)